REPORT ID 14117

United States Avian Influenza Vaccines Market Report 2017

Publish Date
23-Nov-17
Pages
112
Format
Electronic (PDF)

In this report, the United States Avian Influenza Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Avian Influenza Vaccines in these regions, from 2012 to 2022 (forecast).

United States Avian Influenza Vaccines market competition by top manufacturers/players, with Avian Influenza Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Merial
    QYH Biotech
    DHN
    HVRI
    CEVA
    Elanco (Lohmann )
    Yebio
    Zoetis
    FATRO
    Kyoto Biken
    CAVAC
    Ringpu Biology
    Vaksindo
    ChengDu Tecbond

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Type H5
    Type H9
    Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Avian Influenza Vaccines for each application, including
    Chicken
    Duck & Goose
    Other

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Avian Influenza Vaccines Market Report 2017
1 Avian Influenza Vaccines Overview
    1.1 Product Overview and Scope of Avian Influenza Vaccines
    1.2 Classification of Avian Influenza Vaccines by Product Category
        1.2.1 United States Avian Influenza Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Avian Influenza Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Type H5
        1.2.4 Type H9
        1.2.5 Other
    1.3 United States Avian Influenza Vaccines Market by Application/End Users
        1.3.1 United States Avian Influenza Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Chicken
        1.3.3 Duck & Goose
        1.3.4 Other
    1.4 United States Avian Influenza Vaccines Market by Region
        1.4.1 United States Avian Influenza Vaccines Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Avian Influenza Vaccines Status and Prospect (2012-2022)
        1.4.3 Southwest Avian Influenza Vaccines Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Avian Influenza Vaccines Status and Prospect (2012-2022)
        1.4.5 New England Avian Influenza Vaccines Status and Prospect (2012-2022)
        1.4.6 The South Avian Influenza Vaccines Status and Prospect (2012-2022)
        1.4.7 The Midwest Avian Influenza Vaccines Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Avian Influenza Vaccines (2012-2022)
        1.5.1 United States Avian Influenza Vaccines Sales and Growth Rate (2012-2022)
        1.5.2 United States Avian Influenza Vaccines Revenue and Growth Rate (2012-2022)

2 United States Avian Influenza Vaccines Market Competition by Players/Suppliers
    2.1 United States Avian Influenza Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Avian Influenza Vaccines Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Avian Influenza Vaccines Average Price by Players/Suppliers (2012-2017)
    2.4 United States Avian Influenza Vaccines Market Competitive Situation and Trends
        2.4.1 United States Avian Influenza Vaccines Market Concentration Rate
        2.4.2 United States Avian Influenza Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Avian Influenza Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 United States Avian Influenza Vaccines Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Avian Influenza Vaccines Sales and Market Share by Region (2012-2017)
    3.2 United States Avian Influenza Vaccines Revenue and Market Share by Region (2012-2017)
    3.3 United States Avian Influenza Vaccines Price by Region (2012-2017)

4 United States Avian Influenza Vaccines Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Avian Influenza Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Avian Influenza Vaccines Revenue and Market Share by Type (2012-2017)
    4.3 United States Avian Influenza Vaccines Price by Type (2012-2017)
    4.4 United States Avian Influenza Vaccines Sales Growth Rate by Type (2012-2017)

5 United States Avian Influenza Vaccines Sales (Volume) by Application (2012-2017)
    5.1 United States Avian Influenza Vaccines Sales and Market Share by Application (2012-2017)
    5.2 United States Avian Influenza Vaccines Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Avian Influenza Vaccines Players/Suppliers Profiles and Sales Data
    6.1 Merial
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Avian Influenza Vaccines Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Merial Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 QYH Biotech
        6.2.2 Avian Influenza Vaccines Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 QYH Biotech Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 DHN
        6.3.2 Avian Influenza Vaccines Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 DHN Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 HVRI
        6.4.2 Avian Influenza Vaccines Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 HVRI Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 CEVA
        6.5.2 Avian Influenza Vaccines Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 CEVA Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Elanco (Lohmann )
        6.6.2 Avian Influenza Vaccines Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Elanco (Lohmann ) Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Yebio
        6.7.2 Avian Influenza Vaccines Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Yebio Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Zoetis
        6.8.2 Avian Influenza Vaccines Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Zoetis Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 FATRO
        6.9.2 Avian Influenza Vaccines Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 FATRO Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Kyoto Biken
        6.10.2 Avian Influenza Vaccines Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Kyoto Biken Avian Influenza Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 CAVAC
    6.12 Ringpu Biology
    6.13 Vaksindo
    6.14 ChengDu Tecbond

7 Avian Influenza Vaccines Manufacturing Cost Analysis
    7.1 Avian Influenza Vaccines Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Avian Influenza Vaccines

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Avian Influenza Vaccines Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Avian Influenza Vaccines Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Avian Influenza Vaccines Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Avian Influenza Vaccines Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Avian Influenza Vaccines Sales Volume Forecast by Type (2017-2022)
    11.3 United States Avian Influenza Vaccines Sales Volume Forecast by Application (2017-2022)
    11.4 United States Avian Influenza Vaccines Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer